Related Experiment Video
Updated: May 17, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Fecal microbiota transplantation: techniques, applications, and issues
Thomas Julius Borody1, Jordana Campbell
1Centre for Digestive Diseases, Level 1, 229 Great North Road, Five Dock, New South Wales 2046, Australia.
Abstract:
Fecal microbiota transplantation (FMT) has gained widespread recognition in light of the recent Clostridium difficile infection (CDI) epidemic, responsible for almost 110,000 deaths per year. The procedure's success rate has caused experts to reflect on what other conditions may benefit. This article provides an overview of (1) description and history of FMT, (2) FMT publications in CDI, (3) the concept of the gut microbiota as a virtual organ, (4) rationale for FMT use, (5) FMT use in inflammatory bowel disease, (6) emerging FMT applications, (7) how FMT is currently performed, and (8) how FMT may be performed in the future.
Insights
Fecal microbiota transplantation (FMT) is a promising treatment for Clostridium difficile infection (CDI) and may benefit other conditions. This review explores FMT history, applications, and future potential.
Area of Science:
- Microbiology
- Gastroenterology
- Immunology
Background:
- Clostridium difficile infection (CDI) is a significant public health concern, causing substantial mortality.
- The success of fecal microbiota transplantation (FMT) in treating CDI has spurred interest in its broader therapeutic potential.
- The gut microbiota is increasingly recognized as a critical 'virtual organ' influencing host health.
Purpose of the Study:
- To provide a comprehensive overview of fecal microbiota transplantation (FMT).
- To review the history, current applications, and future directions of FMT.
- To discuss the rationale and emerging uses of FMT beyond Clostridium difficile infection.
Main Methods:
- Literature review of FMT publications, focusing on Clostridium difficile infection (CDI) and other conditions.
- Analysis of the concept of the gut microbiota as a functional entity.
- Examination of current and potential future FMT procedures.
Main Results:
- FMT has demonstrated high success rates in managing Clostridium difficile infection (CDI).
- The gut microbiota's role as a 'virtual organ' provides a framework for understanding FMT's efficacy.
- Several emerging applications and future procedural advancements for FMT are identified.
Conclusions:
- Fecal microbiota transplantation (FMT) is a well-established treatment for recurrent Clostridium difficile infection (CDI).
- The understanding of the gut microbiota supports the expansion of FMT to other diseases.
- FMT holds significant promise for future therapeutic interventions, with ongoing research into its application and delivery methods.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Introduction to the Human Microbiota
What is Monogastric Digestion?
Functions of the Gut Microbiota
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Development of Human Microbiota
